+Search query
-Structure paper
Title | H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma. |
---|---|
Journal, issue, pages | Cancer Res., Vol. 77, Page 6999-7013, Year 2017 |
Publish date | Apr 30, 2017 (structure data deposition date) |
Authors | Joshi, J.J. / Coffey, H. / Corcoran, E. / Tsai, J. / Huang, C.L. / Ichikawa, K. / Prajapati, S. / Hao, M.H. / Bailey, S. / Wu, J. ...Joshi, J.J. / Coffey, H. / Corcoran, E. / Tsai, J. / Huang, C.L. / Ichikawa, K. / Prajapati, S. / Hao, M.H. / Bailey, S. / Wu, J. / Rimkunas, V. / Karr, C. / Subramanian, V. / Kumar, P. / MacKenzie, C. / Hurley, R. / Satoh, T. / Yu, K. / Park, E. / Rioux, N. / Kim, A. / Lai, W.G. / Yu, L. / Zhu, P. / Buonamici, S. / Larsen, N. / Fekkes, P. / Wang, J. / Warmuth, M. / Reynolds, D.J. / Smith, P.G. / Selvaraj, A. |
External links | Cancer Res. / PubMed:29247039 |
Methods | X-ray diffraction |
Resolution | 2.2 Å |
Structure data | PDB-5vnd: |
Chemicals | ChemComp-9ES: ChemComp-SO4: ChemComp-EDO: ChemComp-HOH: |
Source |
|
Keywords | transferase/transferase inhibitor / FGFR4 / H3B-56527 / Covalent compound / transferase-transferase inhibitor complex |